Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record◆Adverse 8-K filing
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Sep 3, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 28, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 27, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year200
SEC filings on record1843 flagged findings
Reported transactions (Form 4)58since Jan 22, 2025 · and 40 other holdings
Corporate events (8-K)30since Nov 19, 2024
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Listing notice in force
The exchange has notified the company that it fails a continued-listing requirement (8-K, item 3.01 of Aug 28, 2026).
Deadline: Feb 23, 2027
- unspecified type · Nasdaq, rule 5550(b)(2) · notice of Aug 27, 2026 · delisting determination · deadline Feb 23, 2027 (derived from the rule, not confirmed in the text)
Reverse splits in 5 years
1 reverse split in 5 years (1:75 on Aug 7, 2026) · 1:75 cumulative
The other times: of 771 securities that did their first reverse split in 5 years, a year later the median was worth 0.54× the price on the day of the split; 356 lost more than half and 201 rose (771 with a price a year later).
Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.
The 25 most recent filings (of 184)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Sep 25, 26S-3 ↗Securities offering
- Sep 22, 26SCHEDULE 13G ↗Passive stake · PharmAla Biotech Holdings Inc. · 17.3% · event on Aug 20, 26
- Sep 3, 268-K ↗Current report · Bylaws or fiscal year change
- Aug 28, 26SCHEDULE 13G/A ↗Passive stake · Orca Capital AG · 3.3% · event on Aug 21, 26 · amendment
- Aug 28, 26SCHEDULE 13G ↗Passive stake · Orca Capital AG · 8.4% · event on Aug 21, 26
- Aug 28, 268-K ↗Current report · Listing notice (8-K 3.01)
- Aug 27, 268-K ↗Current report · Entered a material agreement
- Aug 24, 268-K ↗Current report · Other events
- Aug 24, 268-K ↗Current report · Entered a material agreement
- Aug 24, 26424B5 ↗Securities offering
- Aug 14, 2610-Q ↗Quarterly report
- Aug 6, 268-K ↗Current report · Change in shareholder rights · Bylaws or fiscal year change · Other events
- Aug 5, 26Form 4 ↗Insider transaction
- Jul 29, 26424B3 ↗Securities offering
- Jul 28, 268-K ↗Current report · Sold unregistered shares
- Jul 27, 26424B3 ↗Securities offering
- Jul 27, 268-K ↗Current report · Shareholder vote results · Other events
- Jul 22, 26Form 3 ↗Insider transaction
- Jul 21, 26424B3 ↗Securities offering
- Jul 21, 268-K ↗Current report · Entered a material agreement
184 filings on record, the oldest from Oct 12, 21.
Listing the 25 most recent filings of the 184 on record.
3208
- Aug 28, 26Listing notice (8-K 3.01)+2 more in the same filing · the filing reports the decision to delist8-K 3.01 ↗
- Aug 27, 26Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Aug 24, 26Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Jul 28, 26Sold unregistered shares+2 more in the same filing8-K 3.02 ↗
- Jul 21, 26Entered a material agreement+2 more in the same filing8-K 1.01 ↗
3 senior executive changes2026show all 3hide
- Jun 30, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Jun 22, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Jun 5, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- May 21, 26Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Feb 27, 26Listing notice (8-K 3.01)+1 more in the same filing · nominal item 3.01: the filing covers another matter8-K 3.01 ↗
- Feb 20, 26Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Dec 23, 25Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Dec 22, 25A senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
- Nov 20, 25Entered a material agreement+1 more in the same filing8-K/A 1.01 ↗
8 older filings not shown
Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.
- Mar 25, 25Listing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
The full record holds 3 stress filings.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- PharmAla Biotech Holdings Inc.17.3%Aug 20, 26SCHEDULE 13G ↗
- Orca Capital AG3.3%Aug 21, 26SCHEDULE 13G/A ↗1 earlier filing
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
- Jul 1, 25Buy$505CHRISTER ROSENCEO and Chairman↗
- Jul 1, 25Buy$3KCHRISTER ROSENCEO and Chairman↗
- Jul 1, 25Buy$257Alison D. SilvaPres + Chief Business Officer↗
- Jul 1, 25Buy$257Alison D. SilvaPres + Chief Business Officer↗
- Jul 1, 25Buy$259Alison D. SilvaPres + Chief Business Officer↗
- Jun 30, 25Buy$980CHRISTER ROSENCEO and Chairman↗
- Jun 30, 25Buy$2KCHRISTER ROSENCEO and Chairman↗
- Jun 30, 25Buy$1KCHRISTER ROSENCEO and Chairman↗
- Jun 30, 25Buy$721CHRISTER ROSENCEO and Chairman↗
- Jun 30, 25Buy$2KCHRISTER ROSENCEO and Chairman↗
- Jun 30, 25Buy$1KCHRISTER ROSENCEO and Chairman↗
- Jun 30, 25Buy$102Alison D. SilvaPres + Chief Business Officer↗
There are 9 more transactions in this stretch.
Stock compensation, tax and giftsshow the 14 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Mar 2, 26Compensationamount n/aMarshall A. HaywardChief Scientific Officer↗
- Jun 2, 25Compensationamount n/aHolger Weis↗
- Jun 2, 25Compensationamount n/aNicholas H. Hemmerly↗
- Jun 2, 25Compensationamount n/aMarshall A. HaywardChief Scientific Officer↗
- Jun 2, 25Compensationamount n/aMarshall A. HaywardChief Scientific Officer↗
- Jun 2, 25Compensationamount n/aAlexander Gustaf Erik RosenChief Administrative Officer↗
- Jun 2, 25Compensationamount n/aAlexander Gustaf Erik RosenChief Administrative Officer↗
- Jun 2, 25Compensationamount n/aJulie B. Kampf↗
- Jun 2, 25Compensationamount n/aCHRISTER ROSENCEO and Chairman↗
- Jun 2, 25Compensationamount n/aCHRISTER ROSENCEO and Chairman↗
- Jun 2, 25Compensationamount n/aAlison D. SilvaPres + Chief Business Officer↗
- Jun 2, 25Compensationamount n/aSaleem ElmasriCFO and Secretary↗
- Jan 22, 25Compensationamount n/aAllison W Brady↗
- Jan 22, 25Compensationamount n/aHolger Weis↗
The full record holds 35 transactions and goes back to Nov 8, 24.
Its sector and its market
Jupiter Neurosciences Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Jupiter Neurosciences Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Jupiter Neurosciences Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- Series with incidents in the period; the chart shows what could be kept.
- SEC records
- 184 documents on file, from Oct 12, 2021 to Sep 25, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.